Alibaba Health Information Technology Limited
Alibaba Health Information Technology Limited Fundamental Analysis
Alibaba Health Information Technology Limited (ALBHF) shows weak financial fundamentals with a PE ratio of 25.62, profit margin of 5.49%, and ROE of 13.47%. The company generates $41.1B in annual revenue with weak year-over-year growth of 0.98%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 48.7/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze ALBHF's fundamental strength across five key dimensions:
Efficiency Score
WeakALBHF struggles to generate sufficient returns from assets.
Valuation Score
ModerateALBHF shows balanced valuation metrics.
Growth Score
ModerateALBHF shows steady but slowing expansion.
Financial Health Score
ExcellentALBHF maintains a strong and stable balance sheet.
Profitability Score
WeakALBHF struggles to sustain strong margins.
Key Financial Metrics
Is ALBHF Expensive or Cheap?
P/E Ratio
ALBHF trades at 25.62 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, ALBHF's PEG of 0.49 indicates potential undervaluation.
Price to Book
The market values Alibaba Health Information Technology Limited at 3.29 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 24.94 times EBITDA. This signals the market has high growth expectations.
How Well Does ALBHF Make Money?
Net Profit Margin
For every $100 in sales, Alibaba Health Information Technology Limited keeps $5.49 as profit after all expenses.
Operating Margin
Core operations generate 5.24 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $13.47 in profit for every $100 of shareholder equity.
ROA
Alibaba Health Information Technology Limited generates $9.69 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Alibaba Health Information Technology Limited generates limited operating cash flow of $2.02B, signaling weaker underlying cash strength.
Free Cash Flow
Alibaba Health Information Technology Limited produces free cash flow of $2.02B, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.13 in free cash annually.
FCF Yield
ALBHF converts 3.49% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
25.62
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.49
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.29
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.41
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.004
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.71
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.13
vs 25 benchmark
ROA
Return on assets percentage
0.10
vs 25 benchmark
ROCE
Return on capital employed
0.12
vs 25 benchmark
How ALBHF Stacks Against Its Sector Peers
| Metric | ALBHF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 25.62 | 29.77 | Better (Cheaper) |
| ROE | 13.47% | 682.00% | Weak |
| Net Margin | 5.49% | -45016.00% (disorted) | Weak |
| Debt/Equity | 0.00 | 0.42 | Strong (Low Leverage) |
| Current Ratio | 2.71 | 4.49 | Strong Liquidity |
| ROA | 9.69% | -16121.00% (disorted) | Weak |
ALBHF outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Alibaba Health Information Technology Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
316.10%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
945.81%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
113.74%
Industry Style: Defensive, Growth, Innovation
High Growth